English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
Mark your calendar: iCMLf Conversation on October 22nd at 14:00 CEST Highlights of ESH-iCMLf 27th Annual John Goldman Conference on CML: Biology and Therapy
September 2025 - We invite you to join the next iCMLf Conversation on Wednesday, October 22nd, at 14:00 CEST. We will take an in-depth look at the latest CML research and data presented at the ESH-iCMLf 27th Annual John Goldman Conference on CML: Biology and Therapy.
Whether or not you will join us in Estoril on October 10–12, this webinar offers a unique opportunity to hear the key highlights from the conference. Co-chairs Professors Daniela Krause and Jorge Cortes will share their expert perspectives on the most important data presented, discuss its implications for the field, and offer their thoughts on what lies ahead in CML biology and therapy.
This is your chance to gain a concise expert overview of cutting-edge science, benefit from the co-chairs’ insights into both established and emerging trends and put your questions directly to them during the live discussion. Don’t miss the opportunity to engage with global leaders in CML research and explore what’s next for patients and clinicians worldwide.
ESH-iCMLf 27th Annual John Goldman Conference on CML: Biology and Therapy – A first look at the program
August 2025 - This October, the CML community will come together in Estoril, Portugal for the ESH-iCMLf 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy (October 10–12, 2025).
While the program is still being refined by the conference Chairs and Co-organizers, we wanted to give you a flavour of the exciting sessions you can look forward to.
As always, the meeting will be a hub for sharing the latest scientific advancements on CML and fostering collaboration across the global CML network. Building on the strong tradition of scientific excellence, the 2025 program will feature cutting-edge research, interactive workshops, and prize lectures from leaders shaping the future of CML biology and therapy.
We are delighted to share a first glimpse of the program and speakers with you.
iCMLf Research Moves to the World Stage
The iCMLf/HARMONY CML Genomics Project has submitted groundbreaking research to the ASH 2025 Annual Meeting, showcasing how global collaboration is driving progress toward more personalised CML treatment.
Register Now: iCMLf Regional Discussion Groups - Africa 2025
We are pleased to announce the first instalment of our 2024 African regional program to address specific local challenges for physicians treating people with CML. We are starting this year's progam of three zoom-based Regional Discussion Groups on September 25th. Simultaneous interpretation is available in French for all three meetings.
Secure your spot: 2025 John Goldman Fun Run
August 2025 - Start your conference experience at the ESH-iCMLf 27th Annual John Goldman Conference on CML: Biology and Therapy on the right foot – literally!
Lace up for the John Goldman Fun Run on Sunday morning, October 12, before the sessions begin. Organised by the iCMLf, the 5-km run is a fun and meaningful way to connect with colleagues while supporting young CML researchers and physicians from low- and middle-income countries.
Secure your place now and be part of a great team of runners!
Secure your spot: ESH-iCMLf 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy
August 2025 - It’s time to register for ESH-iCMLf 27th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy,, which will be held October 10th –12th, in beautiful Estoril, Portugal.
This annual meeting remains a cornerstone for the global CML community, offering a high-level scientific program that spans the latest insights from disease biology to clinical management and patient care. It’s a unique opportunity to exchange ideas, spark new collaborations, and explore cutting-edge science shaping the future of CML therapy.
